Jared Stephens

Jared Stephens | VP Strategy and Business Development

Jared Stephens leads global strategy and business development for Nanoscope Therapeutics.  Prior to joining Nanoscope, Jared served as Director of Strategy, Search & Evaluation for GE Healthcare with responsibility for inorganic growth strategies across the Cell & Gene Therapy and Genomics business units.  In that capacity, Jared led multiple deals to bring adjacent high growth technologies into the GE fold.

Jared has also served in corporate strategy and leadership roles at multiple startups including Absci and Bionano genomics, both of which went on to IPO and achieve $B plus market caps.  A cell biologist by training, Jared holds a PhD in Cell and Molecular Biology from the University of California, Irvine.

On January 13, 2022   /    
Nanoscope Therapeutics, Inc.
Trinity Towers
2777 N. Stemmons Fwy.
Dallas, TX 75207
(817) 857-1186

  • Dr. Samarendra Mohanty, PhD |  Co-Founder & President

    Samarendra Mohanty (Co-Founder/President) is an inventor & serial entrepreneur with 20+ years experience in Biomedical Sciences. He is Co-Founder of several Biotechs and Biomedical device /diagnostic companies (developed & commercialized $100K+ biomedical instruments.)

    Dr. Mohanty obtained M.Tech in Applied Optics from the Indian Institute of Technology-Delhi and a PhD in (Bio)Physics from the Indian Institute of Sciences-Bangalore.

    His extensive Biomedical Technologies experience includes serving as Professor/Senior Scientist at the University of Texas;  University of California, Irvine; Center for Adv. Tech (India); Int. Mol. Biotech (Germany); Univ. Pavia (Italy); NUS (Singapore); and University of St. Andrews (UK). He has authored over 200 international patents and publications in leading journals including Nature and Nature Photonics.

    He is the Principal Investigator for major grants from the National Eye Institute including Audacious Goal Initiative and Bioengineering Research grants. He serves on the editorial board of journals and chairs an international conference on optogenetics. He is the winner of a 2019 Healthcare Heroes award (Fort Worth Business Press), Retinal Organoid Challenge Award, Audacious Goal Initiative Award (NIH), Finalist of Tech Titan, and NIH-Director’s Innovator Award.